申请人:Boehringer Ingelheim GmbH
公开号:US04039685A1
公开(公告)日:1977-08-02
A compound selected from the group consisting of racemates of 1-phenoxy-2-hydroxy-3-tert.-butylamino propanes of the formula ##STR1## wherein R is selected from the group consisting of alkynyloxy of 2 to 4 carbon atoms, and R.sub.1 is selected from the group consisting of hydrogen, halogen and alkoxy of 1 to 4 carbon atoms, their optically active isomers and their non-toxic, pharmaceutically acceptable acid addition salts of said racemates and said optically active isomers which compounds possess bradycardia activity and isoproterenol antagonistic activity and also antiarrhythmic activity.
从以下组合中选择的化合物:1-苯氧基-2-羟基-3-叔丁基氨基丙烷的混合物,其结构式为##STR1##其中R选择自2至4个碳原子的炔氧基组合,R.sub.1选择自氢、卤素和1至4个碳原子的烷氧基组合,它们的光学活性异构体及其非毒性、药学上可接受的酸盐,这些化合物具有心动过缓活性、异丙肾上腺素拮抗活性以及抗心律失常活性。